Stockreport

SciSparc receives FDA approval for trial for Tourette syndrome therapy [Yahoo! Finance]

SciSparc Ltd.  (SPRC) 
PDF Trial subjects will be randomised into a 1:1 ratio to receive either SCI-110 or a matched placebo. The trial's main efficacy measure is evaluating the variation chang [Read more]